Subscribe to General News

General News

Option Care gains New England foothold

 - 
04/30/2002

PROVIDENCE, R.I. — Option Care entered the New England market in March when it acquired American HomePatient's infusion-pharmacy operations here. The operations generate about $6 million in annual revenue, according to Raj Rai, president and CEO of the Bannockburn, Ill.

AAP: Screen kids for sleep apnea

 - 
04/30/2002

CHICAGO — Pediatricians should screen all kids for chronic snoring, as it's one of the most common symptoms of obstructive sleep apnea syndrome (OSA), according to guidelines recently published by the American Academy of Pediatrics (AAP).

Mobility Express connects the dots

 - 
04/30/2002

HOLIDAY, Fla. — When a consultant recently told HME News that Joe Rached's scooter business was "growing like mad" and "a real success story," he wasn't kidding.

Ostomy fees in the bag

 - 
04/30/2002

WASHINGTON — Providers are describing the recently released fees for the new ostomy codes as "generous," but they're describing the changes in billing they'll have to make to use those fees and codes as "time consuming."

Question & Answer

 - 
04/30/2002

Analyst: HME prospects have never looked better

The ABN: not just about the upgrade

 - 
04/30/2002

LAS VEGAS — The fastest regulatory change coming down the pike shouldn't blind-side suppliers. It's the much-hyped advanced beneficiary notice (ABN), the form advising beneficiaries that Medicare might not cover an item they're purchasing.

Bridges to consumer groups must be built... by June

 - 
04/30/2002

By most accounts AAHomecare's February Leadership Conference was a success.

Legal

 - 
04/30/2002

Making sense of marketing

Home monitoring: down, not out

 - 
04/30/2002

BROOKFIELD, Wis. — If you'd asked a year ago, Buzz Peddicord would have said the home monitoring market for HMEs was dead. Now he's seeing a flickering of life.

"I think the conclusion you can draw is that Innomed wrote a press release that was sufficiently effective in scaring

 - 
04/30/2002

- Analyst Bruce Jacobs of Deutsche Banc Alex Brown in Boston on the stock prices of the nation's two CPAP heavyweights, respironics and resmed, declining sharply following reports that innomed technologies had logged $20 million in sales commitments for its new nasal int

Pages